ClinicalTrials.govpublic full text
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
acute myeloid leukemia, relapse/recurrence, relapsed/refractory, low intensity therapy, pragmatic, low intervention clinical trial, randomized controlled trial, horizon europe, mission cancer, diagnosis and treatment, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 825750
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.